Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients

NCT05504083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: D-0120
DRUG: Benzbromarone

Sponsor

InventisBio Co., Ltd